1. Durable response in the markers of cholestasis through 5 years of open-label extension study of obeticholic acid in primary biliary cholangitis. (February 2020) Authors: Nevens, F.; Shiffman, M.L.; Drenth, J.P.H.; Bowlus, C.L.; Vargas, V.; Andreone, P.; van Erpecum, K.; Floreani, A.; Liberman, A.; Pencek, R.; Malecha, E. Smoot; MacConell, L.; Trauner, M. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Algorithms using noninvasive tests can accurately identify patients with advanced fibrosis due to NASH: data from the STELLAR clinical trials. (February 2019) Authors: Lampertico, P.; Younossi, Z.M.; Lawitz, E.J.; Alkhouri, N.; Wong, V. Wai-Sun; Romero-Gomez, M.; Okanoue, T.; Trauner, M.; Kersey, K.; Li, G.; Subramanian, G.M.; Myers, R.P.; Djedjos, C.S.; Han, L.; Chen, G.; Nguyen, T.; Kohli, A.; Bzowej, N.; Younes, Z.; Sarin, S. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗